杭州启明医疗器械股份有限公司（“启明医疗-B”）于2026年3月4日披露，截至2026年2月28日的证券变动月报表。公告显示，公司本月未新增发行或注销股份，整体股本结构保持稳定。
公司目前已发行H股441,010,235股，非上市外资股1,208股，注册股本总额为人民币441,011,443元，上述数据自上月以来无变化。公告显示，公司曾于2021年12月合计购回3,114,000股H股，截至2026年2月28日，这些购回股份仍未完成注销，本期内无新增购回或注销动作。
此外，公司列示了截至月底尚可行使的股份期权总数为44,101,023股，但当月并无新股因行使期权而发行。公司确认已遵守香港联交所《上市规则》及相关法律法规的要求。
该月报由执行董事柳美荣签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.